Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.8 USD | -9.26% | -8.77% | +13.21% |
Apr. 16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
Apr. 11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.21% | 717M | |
+3.75% | 108B | |
+11.13% | 104B | |
+1.28% | 22.33B | |
-12.86% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.69% | 17.64B | |
+3.64% | 14.05B | |
+37.33% | 12.51B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- Wedbush Lowers AnaptysBio's Price Target to $26 From $29, Keeps Neutral Rating